quinazolines has been researched along with xanthine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, SL; Stribling, R | 1 |
| Deacon, CF; Holst, JJ | 1 |
1 review(s) available for quinazolines and xanthine
| Article | Year |
|---|---|
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes.
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Linagliptin; Molecular Structure; Purines; Quinazolines; Xanthine | 2010 |
1 other study(ies) available for quinazolines and xanthine
| Article | Year |
|---|---|
Attempted nonenzymatic template-directed oligomerizations on a polyadenylic acid template: implications for the nature of the first genetic material.
Topics: Evolution, Molecular; Hydrogen-Ion Concentration; Oligonucleotides; Origin of Life; Phosphorylation; Poly A; Purines; Pyrimidines; Quinazolines; Ribonucleotides; Temperature; Templates, Genetic; Uracil; Uridine Monophosphate; Xanthine | 1991 |